Human influenza viruses and CD8(+) T cell responses

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Influenza A viruses (IAVs) cause substantial global morbidity and mortality.
• Current vaccines are strain-specific, necessitating annual updates.
• CD8(+) T cells offer cross-reactive immunity against diverse IAV strains, driving viral control and recovery.

Purpose of the Study:

• To review current understanding of human CD8(+) T cell responses to IAVs.
• To discuss the potential for a universal T cell vaccine against multiple IAV strains.
• To highlight the role of CD8(+) T cell immunity in susceptible populations.

Main Methods:

• Review of existing literature on human CD8(+) T cell immunity to IAVs.
• Analysis of data from mouse models and human studies.
• Discussion of vaccine development strategies.

Main Results:

• Significant data exists on mouse models, but human epitope-specific CD8(+) T cell responses are less understood.
• CD8(+) T cells are critical for viral control and recovery, independent of neutralizing antibodies.
• Understanding these responses is key for protecting vulnerable groups.

Conclusions:

• A universal CD8(+) T cell-mediated vaccine for influenza is a promising goal.
• Further research into human epitope-specific responses is needed.
• Such a vaccine could offer broad protection across diverse populations and age groups.